{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:21:57Z","timestamp":1792707717680,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.hoc.2022.06.006","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T22:15:08Z","timestamp":1668550508000},"page":"1097-1124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Genetic Modifiers of Sickle Cell Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Thomas","family":"Pincez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison E.","family":"Ashley-Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lettre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn J.","family":"Telen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9861","key":"10.1016\/j.hoc.2022.06.006_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet (London, England)"},{"issue":"4 Suppl","key":"10.1016\/j.hoc.2022.06.006_bib2","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"11","key":"10.1016\/j.hoc.2022.06.006_bib3","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood.V108.11.1201.1201","article-title":"Current prevalence of specific clinical outcomes in adult patients with Hb SS or Hb S\u03b20 thalassemia","volume":"108","author":"Telen","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ajh.23683","article-title":"Factors associated with survival in a contemporary adult sickle cell disease cohort","volume":"89","author":"Elmariah","year":"2014","journal-title":"Am J Hematol"},{"issue":"6 Suppl 4","key":"10.1016\/j.hoc.2022.06.006_bib5","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa: a neglected cause of early childhood mortality","volume":"41","author":"Grosse","year":"2011","journal-title":"Am J Prev Med"},{"issue":"20","key":"10.1016\/j.hoc.2022.06.006_bib6","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1182\/blood-2017-02-765891","article-title":"Treating sickle cell disease by targeting HbS polymerization","volume":"129","author":"Eaton","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.006_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.hoc.2013.11.005","article-title":"Ischemia-reperfusion injury in sickle cell anemia: relationship to acute chest syndrome, endothelial dysfunction, arterial vasculopathy, and inflammatory pain. Review","volume":"28","author":"Hebbel","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.006_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1871529X10909040271","article-title":"A\u00a0systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis. Research support, N.I.H., extramural","volume":"9","author":"Hebbel","year":"2009","journal-title":"Cardiovasc Hematological Disord Drug Targets"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.006_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10739680490278402","article-title":"The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Research support, N.I.H., extramural review","volume":"11","author":"Hebbel","year":"2004","journal-title":"Microcirculation"},{"issue":"12","key":"10.1016\/j.hoc.2022.06.006_bib10","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1182\/blood-2004-01-0042","article-title":"Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions. Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S","volume":"104","author":"Zennadi","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood-2011-03-344440","article-title":"Erythrocyte plasma membrane-bound ERK1\/2 activation promotes ICAM-4-mediated sickle red cell adhesion to endothelium. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't","volume":"119","author":"Zennadi","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2022.06.006_bib12","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1182\/blood-2012-07-441188","article-title":"Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease. Research support, N.I.H., extramural","volume":"121","author":"George","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.006_bib13","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1365-2141.2008.07056.x","article-title":"Fibronectin bridges monocytes and reticulocytes via integrin alpha4beta1","volume":"141","author":"Brittain","year":"2008","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.006_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: multistep and multicellular paradigm","volume":"9","author":"Frenette","year":"2002","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.006_bib15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nm.1939","article-title":"Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury","volume":"15","author":"Hidalgo","year":"2009","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib16","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.052522799","article-title":"Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm","volume":"99","author":"Turhan","year":"2002","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.006_bib17","first-page":"121","article-title":"Platelet-erythrocyte adhesion in sickle cell disease","volume":"47","author":"Wun","year":"1999","journal-title":"J\u00a0Investig Med"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-2143(97)90005-6","article-title":"Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia","volume":"129","author":"Wun","year":"1997","journal-title":"J\u00a0Lab Clin Med"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.006_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/mic.11.2.167.177","article-title":"Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion","volume":"11","author":"Frenette","year":"2004","journal-title":"Microcirculation"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.006_bib20","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1182\/blood.V95.10.3232","article-title":"Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells","volume":"95","author":"Shiu","year":"2000","journal-title":"Blood"},{"issue":"4581","key":"10.1016\/j.hoc.2022.06.006_bib21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/180326a0","article-title":"Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin","volume":"180","author":"Ingram","year":"1957","journal-title":"Nature"},{"issue":"2865","key":"10.1016\/j.hoc.2022.06.006_bib22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.110.2865.543","article-title":"Sickle cell anemia a molecular disease","volume":"110","author":"Pauling","year":"1949","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.006_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(87)90158-9","article-title":"A\u00a0genetic linkage map of the human genome","volume":"51","author":"Donis-Keller","year":"1987","journal-title":"Cell"},{"issue":"5281","key":"10.1016\/j.hoc.2022.06.006_bib24","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1126\/science.273.5281.1516","article-title":"The future of genetic studies of complex human diseases","volume":"273","author":"Risch","year":"1996","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-021-00056-9","article-title":"Genome-wide association studies","volume":"1","author":"Uffelmann","year":"2021","journal-title":"Nat Rev Methods Primers"},{"issue":"6968","key":"10.1016\/j.hoc.2022.06.006_bib26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The international hapmap project","volume":"426","author":"International HapMap","year":"2003","journal-title":"Nature"},{"issue":"7571","key":"10.1016\/j.hoc.2022.06.006_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A\u00a0global reference for human genetic variation","volume":"526","author":"Genomes Project","year":"2015","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.hoc.2022.06.006_bib28","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","article-title":"The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019","volume":"47","author":"Buniello","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.006_bib29","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015032","article-title":"The search for genetic modifiers of disease severity in the beta-hemoglobinopathies","volume":"2","author":"Lettre","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJM198202043060504","article-title":"Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia","volume":"306","author":"Embury","year":"1982","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.hoc.2022.06.006_bib31","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM198206173062402","article-title":"The interaction of alpha-thalassemia and homozygous sickle-cell disease","volume":"306","author":"Higgs","year":"1982","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.hoc.2022.06.006_bib32","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMra1404415","article-title":"The \u03b1-thalassemias","volume":"371","author":"Piel","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.006_bib33","doi-asserted-by":"crossref","first-page":"e1007293","DOI":"10.1371\/journal.pgen.1007293","article-title":"Common alpha-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease","volume":"14","author":"Raffield","year":"2018","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-020-01429-1","article-title":"Non-deletional alpha thalassaemia: a review","volume":"15","author":"Kalle Kwaifa","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/bjh.15038","article-title":"Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies","volume":"180","author":"Vinjamur","year":"2018","journal-title":"Br J Haematol"},{"issue":"10037","key":"10.1016\/j.hoc.2022.06.006_bib36","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/S0140-6736(15)01341-0","article-title":"Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies","volume":"387","author":"Lettre","year":"2016","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.hoc.2022.06.006_bib37","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMct0708272","article-title":"Hydroxyurea for the treatment of sickle cell anemia","volume":"358","author":"Platt","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.hoc.2022.06.006_bib38","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1056\/NEJMoa2000146","article-title":"Hydroxyurea dose escalation for sickle cell anemia in sub-Saharan Africa","volume":"382","author":"John","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.006_bib39","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V79.10.2555.2555","article-title":"Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia","volume":"79","author":"Charache","year":"1992","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.006_bib40","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ng.3793","article-title":"Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci","volume":"49","author":"Canver","year":"2017","journal-title":"Nat Genet"},{"issue":"6155","key":"10.1016\/j.hoc.2022.06.006_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1126\/science.1242088","article-title":"An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level","volume":"342","author":"Bauer","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.006_bib42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib43","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood-2014-03-561779","article-title":"KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of beta-thalassemia","volume":"124","author":"Liu","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2022.06.006_bib44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng.630","article-title":"Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin","volume":"42","author":"Borg","year":"2010","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.hoc.2022.06.006_bib45","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood.2020006425","article-title":"A\u00a0natural DNMT1 mutation elevates the fetal hemoglobin level via epigenetic derepression of the gamma-globin gene in beta-thalassemia","volume":"137","author":"Gong","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2022.06.006_bib46","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ng.707","article-title":"Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation","volume":"42","author":"Galarneau","year":"2010","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.006_bib47","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.amjmed.2008.04.040","article-title":"Surgical and obstetric outcomes in adults with sickle cell disease","volume":"121","author":"Adam","year":"2008","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib48","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/S0021-9258(19)50724-4","article-title":"A\u00a0novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini","volume":"267","author":"Ritter","year":"1992","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12881-019-0899-3","article-title":"Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria","volume":"20","author":"Olatunya","year":"2019","journal-title":"BMC Med Genet"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.006_bib50","doi-asserted-by":"crossref","first-page":"e34741","DOI":"10.1371\/journal.pone.0034741","article-title":"A\u00a0genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia","volume":"7","author":"Milton","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1079-9796(03)00118-9","article-title":"Analysis of the A(TA)(n)TAA configuration in the promoter region of the UGT1 A1 gene in Greek patients with thalassemia intermedia and sickle cell disease","volume":"31","author":"Kalotychou","year":"2003","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.006_bib52","first-page":"188","article-title":"Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia","volume":"90","author":"Chaar","year":"2005","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.006_bib53","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00277-021-04422-1","article-title":"Influence of UGT1A1 promoter polymorphism, alpha-thalassemia and beta(s) haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort","volume":"100","author":"Batista","year":"2021","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.006_bib54","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1182\/blood-2004-02-0521","article-title":"UGT1A1 variation and gallstone formation in sickle cell disease","volume":"105","author":"Haverfield","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.006_bib55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1067\/mlc.2003.28","article-title":"UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia","volume":"141","author":"Heeney","year":"2003","journal-title":"J\u00a0Lab Clin Med"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib56","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2022.06.006_bib57","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/pbc.25655","article-title":"Contribution of sickle cell disease to the pediatric stroke burden among hospital discharges of African-Americans-United States, 1997-2012","volume":"62","author":"Baker","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.hoc.2022.06.006_bib58","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/STROKEAHA.107.483115","article-title":"Confirmation of an association between the TNF(\u2212308) promoter polymorphism and stroke risk in children with sickle cell anemia","volume":"38","author":"Hoppe","year":"2007","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.006_bib59","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2003-09-3015","article-title":"Gene interactions and stroke risk in children with sickle cell anemia","volume":"103","author":"Hoppe","year":"2004","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.hoc.2022.06.006_bib60","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1182\/blood-2011-01-332205","article-title":"Genetic predictors for stroke in children with sickle cell anemia","volume":"117","author":"Flanagan","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.006_bib61","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ng1533","article-title":"Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia","volume":"37","author":"Sebastiani","year":"2005","journal-title":"Nat Genet"},{"issue":"23","key":"10.1016\/j.hoc.2022.06.006_bib62","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.006_bib63","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","article-title":"Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients","volume":"84","author":"Powars","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.hoc.2022.06.006_bib64","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/pbc.24557","article-title":"Sickle cell disease related mortality in the United States (1999-2009)","volume":"60","author":"Hamideh","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.006_bib65","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.12024","article-title":"High one year mortality in adults with sickle cell disease and end-stage renal disease","volume":"159","author":"McClellan","year":"2012","journal-title":"Br J Haematol"},{"issue":"9442","key":"10.1016\/j.hoc.2022.06.006_bib66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"Stuart","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.hoc.2022.06.006_bib67","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1681\/ASN.2002010084","article-title":"Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure","volume":"17","author":"Guasch","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.hoc.2022.06.006_bib68","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-115-8-614","article-title":"Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality","volume":"115","author":"Powars","year":"1991","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.006_bib69","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","article-title":"MYH9 and APOL1 are both associated with sickle cell disease nephropathy","volume":"155","author":"Ashley-Koch","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2022.06.006_bib70","doi-asserted-by":"crossref","first-page":"595702","DOI":"10.3389\/fgene.2021.595702","article-title":"Investigations of kidney dysfunction-related gene variants in sickle cell disease patients in Cameroon (Sub-Saharan Africa)","volume":"12","author":"Ngo-Bitoungui","year":"2021","journal-title":"Front Genet"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.006_bib71","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/bjh.14842","article-title":"Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target","volume":"179","author":"Kormann","year":"2017","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.006_bib72","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3324\/haematol.2015.124875","article-title":"Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy","volume":"100","author":"Saraf","year":"2015","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.006_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164364","article-title":"Genetic modifiers of white blood cell count, albuminuria and glomerular filtration rate in children with sickle cell anemia","volume":"11","author":"Schaefer","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.006_bib74","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/bjh.14724","article-title":"Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon","volume":"178","author":"Geard","year":"2017","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.hoc.2022.06.006_bib75","doi-asserted-by":"crossref","first-page":"e1005349","DOI":"10.1371\/journal.pgen.1005349","article-title":"In\u00a0vivo modeling implicates APOL1 in nephropathy: evidence for dominant negative effects and epistasis under anemic stress","volume":"11","author":"Anderson","year":"2015","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib76","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3324\/haematol.2016.154153","article-title":"APOL1, alpha-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia","volume":"102","author":"Saraf","year":"2017","journal-title":"Haematologica"},{"issue":"5993","key":"10.1016\/j.hoc.2022.06.006_bib77","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.hoc.2022.06.006_bib78","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.3324\/haematol.2018.212779","article-title":"Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life","volume":"104","author":"Zahr","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib79","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/bjh.17832","article-title":"Clinical and genetic factors are associated with kidney complications in African children with sickle cell anaemia","volume":"196","author":"Adebayo","year":"2022","journal-title":"Br J Haematol"},{"issue":"15","key":"10.1016\/j.hoc.2022.06.006_bib80","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/blood-2018-05-853929","article-title":"HMOX1 and acute kidney injury in sickle cell anemia","volume":"132","author":"Saraf","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib81","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cell.2019.02.032","article-title":"Genomic analysis in the age of human genome sequencing","volume":"177","author":"Lappalainen","year":"2019","journal-title":"Cell"},{"issue":"7845","key":"10.1016\/j.hoc.2022.06.006_bib82","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","article-title":"Sequencing of 53,831 diverse genomes from the NHLBI TOPMed program","volume":"590","author":"Taliun","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41380-021-01201-2","article-title":"Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction","volume":"27","author":"Guan","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib84","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13059-020-1935-5","article-title":"Opportunities and challenges in long-read sequencing data analysis","volume":"21","author":"Amarasinghe","year":"2020","journal-title":"Genome Biol"},{"issue":"11","key":"10.1016\/j.hoc.2022.06.006_bib85","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrg3933","article-title":"Genetic variation and the de novo assembly of human genomes","volume":"16","author":"Chaisson","year":"2015","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib86","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1038\/s41467-019-12869-0","article-title":"Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders","volume":"10","author":"Oetjens","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib87","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","article-title":"Polygenic risk scores: from research tools to clinical instruments","volume":"12","author":"Lewis","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.hoc.2022.06.006_bib88","article-title":"Variation and impact of polygenic hematological traits in monogenic sickle cell disease","author":"Pincez","year":"2022","journal-title":"medRxiv"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.006_bib89","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1182\/bloodadvances.2017009811","article-title":"g(HbF): a genetic model of fetal hemoglobin in sickle cell disease","volume":"2","author":"Gardner","year":"2018","journal-title":"Blood Adv"},{"issue":"14","key":"10.1016\/j.hoc.2022.06.006_bib90","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/bloodadvances.2021004634","article-title":"A\u00a0polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease","volume":"5","author":"Rampersaud","year":"2021","journal-title":"Blood Adv"},{"issue":"21","key":"10.1016\/j.hoc.2022.06.006_bib91","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra2101920","article-title":"Somatic mutations in \u201cbenign\u201d disease","volume":"384","author":"Mustjoki","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.006_bib92","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.tig.2021.06.012","article-title":"Somatic mutations provide important and unique insights into the biology of complex diseases","volume":"37","author":"Olafsson","year":"2021","journal-title":"Trends Genet"},{"issue":"6465","key":"10.1016\/j.hoc.2022.06.006_bib93","doi-asserted-by":"crossref","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.hoc.2022.06.006_bib94","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.hoc.2022.06.006_bib95","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.006_bib96","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.hoc.2022.06.006_bib97","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1182\/blood.2021011121","article-title":"Clonal hematopoiesis in sickle cell disease","volume":"138","author":"Pincez","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.006_bib98","doi-asserted-by":"crossref","first-page":"e156060","DOI":"10.1172\/JCI156060","article-title":"Clonal hematopoiesis in sickle cell disease","volume":"132","author":"Liggett","year":"2022","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"issue":"19","key":"10.1016\/j.hoc.2022.06.006_bib100","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2022.06.006_bib101","doi-asserted-by":"crossref","first-page":"102504","DOI":"10.1016\/j.bcmd.2020.102504","article-title":"Potential causal role of l-glutamine in sickle cell disease painful crises: a Mendelian randomization analysis","volume":"86","author":"Ilboudo","year":"2021","journal-title":"Blood Cells Mol Dis"},{"issue":"10197","key":"10.1016\/j.hoc.2022.06.006_bib102","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(19)31276-0","article-title":"Pharmacogenomics","volume":"394","author":"Roden","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib103","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cpt.1651","article-title":"The clinical pharmacogenetics implementation consortium: 10 years later","volume":"107","author":"Relling","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"18","key":"10.1016\/j.hoc.2022.06.006_bib104","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2011-07-364190","article-title":"Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia","volume":"118","author":"Ware","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.006_bib105","doi-asserted-by":"crossref","first-page":"e110740","DOI":"10.1371\/journal.pone.0110740","article-title":"Whole exome sequencing identifies novel genes for fetal hemoglobin response to hydroxyurea in children with sickle cell anemia","volume":"9","author":"Sheehan","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.006_bib106","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A\u00a0phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.006_bib107","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1903212","article-title":"A\u00a0phase 3 randomized trial of voxelotor in sickle cell disease","volume":"381","author":"Vichinsky","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib108","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.hoc.2022.06.006_bib109","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Optimizing primary stroke prevention in sickle cell anemia trial I. discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib111","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1537-2995.2007.01622.x","article-title":"Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease","volume":"48","author":"Afenyi-Annan","year":"2008","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ajh.21058","article-title":"Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes","volume":"83","author":"De Castro","year":"2008","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.006_bib113","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Innovation: metabolomics: the apogee of the omics trilogy","volume":"13","author":"Patti","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.006_bib114","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/bjh.15592","article-title":"Plasma metabolomics analysis in sickle cell disease patients with albuminuria - an exploratory study","volume":"185","author":"Elsherif","year":"2019","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.hoc.2022.06.006_bib115","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/1535370216640150","article-title":"Minireview: multiomic candidate biomarkers for clinical manifestations of sickle cell severity: early steps to precision medicine","volume":"241","author":"Goodman","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"issue":"12","key":"10.1016\/j.hoc.2022.06.006_bib116","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/ajh.25263","article-title":"Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease","volume":"93","author":"Xu","year":"2018","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib117","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease","volume":"325","author":"Platt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.hoc.2022.06.006_bib118","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/bloodadvances.2017005231","article-title":"Associations of \u03b1-thalassemia and BCL11A with stroke in Nigerian, United States, and United Kingdom sickle cell anemia cohorts","volume":"1","author":"Saraf","year":"2017","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.006_bib119","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/bjh.13916","article-title":"Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study","volume":"172","author":"Sommet","year":"2016","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.hoc.2022.06.006_bib120","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00277-020-04079-2","article-title":"Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia","volume":"99","author":"Sales","year":"2020","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.006_bib121","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood.V74.4.1403.1403","article-title":"Leg ulcers in patients with sickle cell disease","volume":"74","author":"Koshy","year":"1989","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib122","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0609.2011.01705.x","article-title":"The alpha-globin genotype does not influence sickle cell disease severity in a retrospective cross-validation study of the pediatric severity score","volume":"88","author":"Joly","year":"2012","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.006_bib123","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jpeds.2011.07.018","article-title":"Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia","volume":"160","author":"Darbari","year":"2012","journal-title":"J\u00a0Pediatr"},{"issue":"8743","key":"10.1016\/j.hoc.2022.06.006_bib124","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0140-6736(91)90322-G","article-title":"Is the painful crisis of sickle-cell disease due to sickling?","volume":"337","author":"Bailey","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.006_bib125","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood.V86.2.776.bloodjournal862776","article-title":"Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative study of sickle cell disease [see comments]","volume":"86","author":"Gill","year":"1995","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2022.06.006_bib126","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1182\/blood.V86.11.4382a.bloodjournal86114382a","article-title":"Paradoxical increase of painful crises in sickle cell patients with alpha-thalassemia [letter; comment]","volume":"86","author":"Billett","year":"1995","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.006_bib127","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.V63.6.1353.1353","article-title":"Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia","volume":"63","author":"Steinberg","year":"1984","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2022.06.006_bib128","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/00043426-200308000-00007","article-title":"Alpha thalassemia is associated with decreased risk of abnormal transcranial doppler ultrasonography in children with sickle cell anemia","volume":"25","author":"Hsu","year":"2003","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.006_bib129","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.3324\/haematol.2020.265827","article-title":"Genome wide association study of silent cerebral infarction in sickle cell disease (HbSS and HbSC)","volume":"106","author":"Brewin","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.006_bib130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-3476(05)80897-2","article-title":"Stroke in a cohort of patients with homozygous sickle cell disease","volume":"120","author":"Balkaran","year":"1992","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib131","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0022-3476(88)80013-1","article-title":"Cerebrovascular accidents in children with sickle-cell disease and alpha-thalassemia","volume":"113","author":"Miller","year":"1988","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.006_bib132","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajh.2830450402","article-title":"Alpha thalassemia and stroke risk in sickle cell anemia","volume":"45","author":"Adams","year":"1994","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib133","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00251-017-1013-7","article-title":"Variants in the non-coding region of the TLR2 gene associated with infectious subphenotypes in pediatric sickle cell anemia","volume":"70","author":"David","year":"2017","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.006_bib134","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/(SICI)1096-8652(199705)55:1<24::AID-AJH4>3.0.CO;2-5","article-title":"Sickle cell disorder, \u03b2-globin gene cluster haplotypes and \u03b1-thalassemia in neonates and adults from Guadeloupe","volume":"55","author":"K\u00e9clard","year":"1997","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.006_bib135","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood.V62.2.286.286","article-title":"Alpha-thalassemia is related to prolonged survival in sickle cell anemia","volume":"62","author":"Mears","year":"1983","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib136","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1182\/blood.V88.5.1898.1898","article-title":"Age dependence of the gene frequency of alpha-thalassemia in sickle cell anemia in Cuba [letter]","volume":"88","author":"Martinez","year":"1996","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.006_bib137","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood.V64.5.1042.1042","article-title":"Dense cells in sickle cell anemia: the effects of gene interaction","volume":"64","author":"Fabry","year":"1984","journal-title":"Blood"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858822000648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858822000648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:18:02Z","timestamp":1760185082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858822000648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":137,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0889858822000648"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2022.06.006","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic Modifiers of Sickle Cell Disease","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2022.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}